Medical Device News Magazine

Dr. Catherine Y Spong New Editor-in-Chief of Contemporary OB/GYN®

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Contemporary OB/GYN®, a multimedia platform that provides obstetricians and gynecologists with expert advice and critical articles from top-tier physician-authors, announced that Dr. Catherine Y Spong is their new editor-in-chief.

“Aside from the strong clinical expertise that Spong brings to Contemporary OB/GYN®, her experiences also provide a unique set of perspectives on broad aspects of the OB-GYN practice,” said Mike Hennessy Jr., president, and CEO of MJH Life Sciences, the parent company of Contemporary OB/GYN®. “As we continue to enhance our content portfolio for our readers, we are excited to welcome Spong and carry out her initiative to provide clear, concise, plain-language insight on topics confronted by OB-GYNs in day-to-day practice.”

Spong is a professor and vice-chair in the department of obstetrics and gynecology at The University of Texas Southwestern Medical Center, where she also serves as the chief of the department’s division of maternal-fetal medicine. Spong specializes in prematurity, fetal complications, and improving outcomes in children. Her clinical responsibilities are in the Parkland Health and Hospital System in Dallas. She holds the Gillette professorship of obstetrics and gynecology.

“While Spong’s professional focus lies in the field of obstetrics, her vision for Contemporary OB/GYN® goes well beyond that aspect of female care,” said Aviva Belsky, group publisher of Contemporary OB/GYN®. “In catering our content to the current learners of the specialty, we hope to address the topical issues faced by experts in the field and expand our venues for information dissemination.”

Spong’s all-encompassing research interests include the developing fetus, improving the understanding of stillbirth, fetal surgery for myelomeningocele, Zika in pregnancy and the human placenta. She holds several patents for neuroprotective agents that help prevent fetal injury. Spong is also a passionate advocate for inclusion in research for underrepresented groups.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”